TRANSDIFFERENTIATION OF NEOPLASM

TRANSDIFFERENTIATION OF NEOPLASM was reported 58 times

TRANSDIFFERENTIATION OF NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LAROTRECTINIB 1 0.0011
1 ETHIODIZED OIL 1 0.0008
2 ESTROGEN 2 0.0007
3 BREXUCABTAGENE AUTOLEUCEL 1 0.0005
4 BLEOMYCIN SULFATE 4 0.0004
5 INOTUZUMAB OZOGAMICIN 1 0.0003
6 VINORELBINE 2 0.0003
7 IFOSFAMIDE FOR INJECTION 6 0.0003
8 ERLOTINIB HYDROCHLORIDE 3 0.0002
9 BICALUTAMIDE 3 0.0002
10 OXALIPLATIN 14 0.0002
11 EPIRUBICIN HYDROCHLORIDE 1 0.0002
12 OSIMERTINIB 5 0.0002
13 ETOPOSIDE 11 0.0001
14 ALECTINIB HYDROCHLORIDE 1 0.0001
15 DACARBAZINE 1 0.0001
16 FLUOROURACIL CREAM, 0.5% 10 0.0001
17 FLUOROURACIL 10 0.0001
18 DOCETAXEL 8 0.0001
19 DOCETAXEL ANHYDROUS 8 0.0001
20 PEMETREXED DISODIUM 4 0.0001
21 BLINATUMOMAB 1 0.0001
22 CISPLATIN 7 0.0001
23 GOSERELIN 1 0.0001
24 DOXORUBICIN HYDROCHLORIDE 2 0.0001
25 GEMCITABINE HYDROCHLORIDE 3 0.0001
26 DOXORUBICIN 5 0.0001
27 ATEZOLIZUMAB 2 0.0001
28 DURVALUMAB 1 0.0000
29 CARBOPLATIN 6 0.0000
30 VINCRISTINE SULFATE 1 0.0000
31 CYCLOPHOSPHAMIDE FOR INJECTION 5 0.0000
32 CYCLOPHOSPHAMIDE 5 0.0000
33 FILGRASTIM 1 0.0000
34 LEUPROLIDE ACETATE 2 0.0000
35 FLUDARABINE PHOSPHATE 1 0.0000
36 ZOLEDRONIC ACID 1 0.0000
37 ESTRADIOL 2 0.0000
38 CYTARABINE 1 0.0000
39 BEVACIZUMAB 2 0.0000
40 VENETOCLAX 1 0.0000
41 IBRUTINIB 1 0.0000
42 PACLITAXEL 1 0.0000
43 PEMBROLIZUMAB 1 0.0000
44 RITUXIMAB 1 0.0000
45 DEXAMETHASONE 1.5 MG 1 0.0000
46 DEXAMETHASONE 1 0.0000